Jason T Yustein Selected Research

Jason T Yustein Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 07/2010
9	Osteosarcoma (Osteogenic Sarcoma) 05/2021 - 07/2015
5	Neoplasm Metastasis (Metastasis) 05/2021 - 11/2017
4	Ewing Sarcoma (Sarcoma, Ewing) 01/2021 - 11/2010
2	Hypoxia (Hypoxemia) 01/2021 - 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2019
1	Triple Negative Breast Neoplasms 12/2019
1	Hemangiosarcoma (Angiosarcoma) 12/2019
1	Sarcoma (Soft Tissue Sarcoma) 11/2017
1	Necrosis 11/2015
1	Rupture 07/2010
1	Carcinogenesis 02/2010
1	Burkitt Lymphoma (Burkitt's Lymphoma) 07/2007
1	Hematologic Neoplasms (Hematological Malignancy) 07/2007

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 05/2021 - 07/2015
3	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2018
2	WD repeat containing planar cell polarity effectorIBA 05/2021 - 11/2016
2	Monoclonal AntibodiesIBA 05/2021 - 12/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2021 - 01/2020
2	CateninsIBA 01/2021 - 11/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 12/2019
2	EWS-FLI fusion proteinIBA 01/2020 - 11/2010
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2017
1	Immune Checkpoint InhibitorsIBA 05/2021
1	Immunoglobulin G (IgG)IBA 05/2021
1	Transcription Factors (Transcription Factor)IBA 05/2021
1	p21-Activated KinasesIBA 01/2021
1	ras ProteinsIBA 01/2021
1	PF 3758309IBA 01/2021
1	KPT-9274IBA 01/2021
1	InterferonsIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	ponatinibIBA 10/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Drug CombinationsIBA 01/2020
1	Ifosfamide FDA LinkGeneric 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 12/2019
1	Long Noncoding RNAIBA 01/2019
1	Lactate Dehydrogenase 5IBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	Core Binding Factor Alpha 1 SubunitIBA 11/2015
1	Caspase 3 (Caspase-3)IBA 11/2015
1	Oncogene Proteins (Oncogene Protein)IBA 11/2010
1	YK 4-279IBA 11/2010
1	Aldehyde DehydrogenaseIBA 11/2010
1	Capsules (Microcapsules)IBA 07/2010
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 02/2010
1	Biological ProductsIBA 07/2007

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 12/2020 - 11/2010
5	Therapeutics 05/2021 - 08/2013
2	Immunotherapy 01/2022 - 01/2021
1	Radiotherapy 01/2018